Perth, Western Australia, 02 August 2019: Proteolytics Pty Ltd, a clinical-stage biotechnology company developing novel therapeutics for advanced wound care and skin disorders, today announced a proposed comparative in-vivo study

Continue

Perth, Western Australia, 22 July 2019: Proteolytics Pty Ltd, a clinical-stage biotechnology company developing novel therapeutics for advanced wound care and skin disorders, today announced that an evaluation of the

Continue

Perth, Western Australia, 12 July 2019: Proteolytics Pty Ltd, a clinical-stage biotechnology company developing novel therapeutics for advanced wound care and skin disorders, today announced that initial results from an

Continue

Perth, Western Australia, 05 July 2019: Proteolytics Pty Ltd, a clinical-stage biotechnology company developing novel therapeutics for advanced wound care and skin disorders, today announced that it is collaborating with

Continue

Proteolytics Forms Medical & Scientific Advisory Committee. Three members recognised as industry experts in wound care. Click here to view announcement

Continue